Skip to main content
SpringerLink
Log in

Niosomes as transdermal drug delivery system for celecoxib: in vitro and in vivo studies

  • Original Paper
  • Published:
Polymer Bulletin Aims and scope Submit manuscript

Abstract

Nonionic surfactant vesicles containing celecoxib (CXB) as an anti-inflammatory drug were prepared using, Span 60 or Span 40 and cholesterol in the ratios of 1:0, 1:1 and 1:2. Prepared vesicles were characterized for encapsulation efficiency, particle size and drug release. The drug encapsulation efficiencies varied from 60.55 to 80.35 %. The vesicle size ranged from 170 to 235 nm. The high encapsulation was achieved by the ratio 1:1 of span 60:cholesterol and this formula showed significant in vitro release of the drug (80 %) as compared to other forms (P < 0.05). Among niosomal gels investigated, poloxamer 407 niosomal gel showed significant drug release (72 % after 12 h) over the other forms (P < 0.05). The results also showed that the release of CXB from the niosomes and niosomal gels obeyed the Higuchi’s diffusion model. The anti-inflammatory activity of the drug from different niosomal gel formulations was also studied using Carrageenan-induced rat paw edema method. The results showed that there is significant anti-inflammatory activity (75.45 %) of the poloxamer niosomal gel on rat paw edema (P < 0.05).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Barry BW (2001) Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci 14:101–114

    Article  CAS  Google Scholar 

  2. Shakeel F, Shafiq S, Haq N, Alanazi FK, Alsarra IA (2012) Nanoemulsions as vehicles for transdermal and dermal delivery of hydrophobic compounds: an overview. Expert Opin Drug Deliv 9:953–974

    Article  CAS  Google Scholar 

  3. El-Badry M, Fetih G, Shakeel F (2014) Comparative topical delivery of croconazole using liposome and microemulsion-based gel formulations. Drug Deliv 21:34–43

    Article  CAS  Google Scholar 

  4. Trommer H, Neubert RHH (2006) Overcoming the stratum corneum: the modulation of skin penetration. a review. Skin Pharm Physiol 19:106–121

    Article  CAS  Google Scholar 

  5. Ah YC, Choi JK, Choi YK, Ki HM, Bae JH (2010) A novel transdermal patch incorporating meloxicam: in vitro and in vivo characterization. Int J Pharm 385:12–19

    Article  CAS  Google Scholar 

  6. Shakeel F, Haq N, Al-Dhfyan A, Alanazi FK, Alsarra IA (2015) Chemoprevention of skin cancer using low HLB surfactant nanoemulsion of 5-fluorouracil. Drug Deliv 22:573–580

    Article  CAS  Google Scholar 

  7. Williams AC, Barry BW (2004) Penetration enhancers. Adv Drug Deliv Rev 56:603–618

    Article  CAS  Google Scholar 

  8. El-Badry M, Fetih G, Fathalla D, Shakeel F (2015) Transdermal delivery of meloxicam using niosomal hydrogels: in vitro and pharmacodynamic evaluation. Pharm Develop Technol 20:820–826

    Article  CAS  Google Scholar 

  9. Handjani-Vila RM, Rlbier A, Rondot B, Vanlerberghe G (1979) Dispersions of lamellar phases of non-ionic lipids in cosmetic products. Int J Cosmetic Sci 1:303–305

    Article  CAS  Google Scholar 

  10. Marianecci C, Di Marzio L, Rinaldi F, Celia C, Paolino D, Alhaique F, Esposito R, Carafa M (2014) Niosomes from 80 s to present: the state of the art. Adv Coll Interf Sci 205:187–206

    Article  CAS  Google Scholar 

  11. Moghassemi S, Hadjizadeh A (2014) Nano-niosomes as nanoscale drug delivery systems: an illustrated review. J Controll Rel 185:22–36

    Article  CAS  Google Scholar 

  12. Manconi M, Valenti D, Sinico C, Lai F, Loy G, Fadda AM (2003) Niosomes as carriers for tretinoin II. Influence of vesicular incorporation on tretinoin photostability. Int J Pharm 260:261–263

    Article  CAS  Google Scholar 

  13. Luciani A, Olivier JC, Clement O, Siauve N, Brillet PY, Borsoud B (2004) Glucose-receptor MR imaging of tumors: study in mice with PEGylated paramagnetic niosomes. Radiol 231:135–142

    Article  Google Scholar 

  14. Lala S, Pramanick S, Mukhopadhyay S, Bandyopadhyay S, Basu MK (2004) Harmine: evaluation of its antileishmanial properties in various vesicular delivery systems. J Drug Target 12:165–168

    Article  CAS  Google Scholar 

  15. Shahiwala A, Misra A (2002) Studies in topical application of niosomally entrapped nimesulide. J Pharm Pharm Sci 5:220–225

    CAS  Google Scholar 

  16. Patel KK, Kumar P, Thakkar HP (2012) Formulation of niosomal gel for enhanced transdermal lopinavir delivery and its comparative evaluation with ethosomal gel. AAPS Pharm Sci Tech 13:1502–1510

    Article  CAS  Google Scholar 

  17. Bayindir ZS, Yuksel N (2010) Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery. J Pharm Sci 99:2049–2060

    Article  CAS  Google Scholar 

  18. Abdel-Kader H, Ismail S, Kamal A, Alany RG (2011) Design and evaluation of controlled-release niosomes and discomes for naltrexone hydrochloride ocular delivery. J Pharm Sci 100:1833–1846

    Article  CAS  Google Scholar 

  19. Davies NM, McLachlam AJ, Day RO, Williams KM (2000) Clinical pharmacokinetics and pharmacodynamics of celecoxib: a selective cyclooxygenase-2 inhibitor. Clin Pharm 38:225–242

    Article  CAS  Google Scholar 

  20. Tindall E (1999) Celecoxib for the treatment of pain and inflammation: the preclinical and clinical results. J Am Osteopath Assoc 99:S13–S17

    Article  CAS  Google Scholar 

  21. Ventura CA, Giannone I, Paolino D, Pistara V, Corsaro A, Puglisi G (2005) Preparation of celecoxib-dimethyl-β-cyclodextrin inclusion complex: characterization and in vitro permeation study. Eur J Med Chem 40:624–631

    Article  CAS  Google Scholar 

  22. Paulson SK, Kaprak TA, Gresk CJ, Fast DM, Baratta MT, Burton EG, Breau AP, Karim A (1999) Plasma protein binding of celecoxib in mice, rat, rabbit, dog and human. Biopharm Drug Dispos 20:293–299

    Article  CAS  Google Scholar 

  23. Paulson SK, Vaughn MB, Jessen SM, Lawal Y, Gresk CJ, Yan B, Maziasz TJ, Cook CS, Karim A (2001) Pharmacokinetics of celecoxib after oral administration in dogs and humans, effect of food and site of absorption. J Pharmacol Exp Ther 297:638–645

    CAS  Google Scholar 

  24. Chan AT, Jauber AG, Hsu M, Breazna A, Hunter DJ, Rosenstein RB, Eagle CJ, Hawak ET, Bertagnolli MM (2009) Cytochrome P450 2C9 variants influence response to celecoxib for prevention of colorectal adenoma. Gasrtoentrol 136:2127–2136

    Article  CAS  Google Scholar 

  25. Pankaj PK, Bhanubhai NS, Anil B, Jivani NP (2011) Design, synthesis and pharmacological screening of 1-acetyl-3-aryl-5-(4-methoxyphenyl)pyrazoles as a potential anti-inflammatory agents. Der Pharm Sinica 2:194–200

    Google Scholar 

  26. Solomon SD, McMurray JJV, Pfeffer MA, Wittes J, Fowler R, Finn P, Anderson WF, Zauber A, Hawk E, Bertagnolli M (2005) Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. New Eng J Med 352:1071–1080

    Article  CAS  Google Scholar 

  27. Subramanian N, Ghosal SK, Moulik SP (2005) Enhanced in vitro percutaneous absorption and in vivo anti-inflammatory effect of a selective cyclooxygenase inhibitor using microemulsion. Drug Develop Ind Pharm 31:405–416

    Article  CAS  Google Scholar 

  28. Jain SK, Gupta Y, Jain A, Bhola M (2007) Multivesicular liposomes bearing celecoxib-beta-cyclodextrin complex for transdermal delivery. Drug Deliv 14:327–335

    Article  CAS  Google Scholar 

  29. Kaur K, Jain S, Sapra B, Tiwary AK (2007) Niosomal gel for site-specific sustained delivery of anti-arthritic drug: in vitro-in vivo evaluation. Curr Drug Deliv 4:276–282

    Article  CAS  Google Scholar 

  30. Shakeel F, Baboota S, Ahuja A, Ali J, Shafiq S (2008) Celecoxib nanoemulsion: skin permeation mechanism and bioavailability assessment. J Drug Target 16:733–740

    Article  CAS  Google Scholar 

  31. Alam MI, Baboota S, Kohli K, Ali J, Ahuja A (2009) Development and evaluation of transdermal patches of celecoxib. PDA J Pharm Sci Technol 63:429–437

    CAS  Google Scholar 

  32. Shakeel F, Baboota S, Ahuja A, Ali J, Shafiq S (2009) Celecoxib nanoemulsion for transdermal drug delivery: characterization and in vitro evaluation. J Disp Sci Technol 30:834–842

    Article  CAS  Google Scholar 

  33. Soliman SM, Malak NSA, El-Gazayerly ON, Rehim AAA (2010) Formulation of microemulsion gel system for transdermal delivery of celecoxib: in vitro permeation, anti-inflammatory activity and skin irritation tests. Drug Discov Ther 4:459–471

    CAS  Google Scholar 

  34. Bragagni M, Mennini N, Maestrelli F, Cirri M, Mura P (2012) Comparative study of liposomes, transferosomes and ethosomes as carriers for improving topical delivery of celecoxib. Drug Deliv 19:354–361

    Article  CAS  Google Scholar 

  35. Quinonones OG, Mata Dos Santos HA, Kibwila DM, Leitao A, Dos Santos Pyrrho A, Padula MD, Rosas EC, Lara MG, Pierre MB (2014) In vitro and in vivo influence of penetration enhancers in the topical application of celecoxib. Drug Develop Ind Pharm 40:1180–1189

    Article  Google Scholar 

  36. Shamsher AA, Charoo NA, Rahman Z, Pillai KK, Kohli K (2014) Tulsi oil as a penetration enhancer for celecoxib transdermal gel formulations. Pharm Develop Technol 19:21–30

    Article  CAS  Google Scholar 

  37. Mokhtar M, Sammour OA, Hammad MA, Megrab NA (2008) Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. Int J Pharm 361:104–111

    Article  CAS  Google Scholar 

  38. El-Badry M, Fetih G (2011) Preparation, characterization and anti-inflammatory activity of celecoxib chitosan gel formulations. J Drug Deliv Sci Technol 21:201–206

    Article  CAS  Google Scholar 

  39. Aggarwal D, Pal D, Mitra AK, Kaur IP (2007) Study of the extent of ocular absorption of acetazolamide from a developed niosomal formulation by microdialysis sampling of aqueous humor. Int J Pharm 338:21–26

    Article  CAS  Google Scholar 

  40. Schmalka IR (1972) Artificial-skin I. Preparation of pluronic F-127 gels for treatment of burns. J Biomed Matter Res 6:571–582

    Article  Google Scholar 

  41. Varshosaz J, Tabbakhian M, Salmani Z (2008) Design of a thermosensitive chitosan/poloxamer in situ gel for ocular delivery of ciprofloxacin. Open Drug Deliv J 2:61–70

    Article  CAS  Google Scholar 

  42. Al-Suwayeh SA (2003) Transdermal delivery of isradipine through excised rabbit skin effect of vehicle and drug concentration. Saudi Pharm J 11:46–52

    CAS  Google Scholar 

  43. Escribano E, Calpena AC, Queralt J, Obach R, Domenench J (2003) Assessment of diclofenac permeation with different formulations: anti-inflammatory study of a selected formula. Eur J Pharm Sci 19:203–210

    Article  CAS  Google Scholar 

  44. Wada Y, Etoh Y, Ohira A, Kimata H, Koide T, Ishihama H, Mizushima Y (1982) Percutaneous absorbtion and anti-inflammatory activity of indomethacin in ointment. J Pharm Pharmcol 34:467–468

    Article  CAS  Google Scholar 

  45. El-Menshawe SF, Hussein AK (2013) Formulation and evaluation of meloxicam niosomes as vesicular carriers for enhanced skin delivery. Pharm Dev Technol 18:779–786

    Article  CAS  Google Scholar 

  46. Abdelbary G, El-Gendy N (2008) Niosome-encapsulated gentamicin for ophthalmic controlled delivery. AAPS Pharm Sci Tech 9:740–747

    Article  CAS  Google Scholar 

  47. Ruckmani K, Sankar V (2010) Formulation and optimization of zidovudine niosomes. AAPS Pharm Sci Tech 11:1119–1127

    Article  CAS  Google Scholar 

  48. El-Samaligy MS, Afifi NN, Mahmoud EA (2006) Increasing bioavailability of silymarin using a buccal liposomal delivery system: preparation and experimental design investigation. Int J Pharm 308:140–148

    Article  CAS  Google Scholar 

  49. Losada-Perez P, Khorshid M, Yongabi D, Wanger P (2015) Effect of cholesterol on the phase behavior of solid-supported lipid vesicle layers. J Phys Chem B 119:4985–4992

    Article  CAS  Google Scholar 

  50. Pozzi D, Caminiti R, Marianecci C, Carafa M, Santucci E, De Sanctis SC, Caracciolo G (2010) Effect of cholesterol on the formation and hydration behavior of solid-supported niosomal membranes. Langmuir 26:2268–2273

    Article  CAS  Google Scholar 

  51. Ning M, Guo Y, Pan H, Chen X, Gu Z (2005) Preparation, in vitro and in vivo evaluation of liposomal/niosomal gel delivery systems for clotrimazole. Drug Dev Ind Pharm 31:375–383

    Article  CAS  Google Scholar 

  52. Billard A, Pourchet L, Malaise S, Alcouffe P, Montembault A, Ladavière C (2015) Liposome-loaded chitosan physical hydrogel: toward a promising delayed-release biosystem. Polyhydr Polym 115:651–657

    CAS  Google Scholar 

  53. Carafa M, Marianecci C, Di Marzio L, Rinaldi F, Meo C, Matricardi P, Alhaique F, Coviello T (2011) A new vesicle-loaded hydrogel system suitable for topical applications: preparation and characterization. J Pharm Pharm Sci 14:336–346

    Google Scholar 

  54. Hilton J, Woolen BH, Scott RC, Auton TR, Trebilock KL, Wilks MF (1994) Vehicle effects on the in vitro percutaneous absorption through rat and human skin. Pharm Res 11:1396–1400

    Article  CAS  Google Scholar 

Download references

Acknowledgments

The authors would like to extend their sincere appreciation to the Deanship of Scientific Research at King Saud University for its funding the work through the research group Project No. RGP-299.

Author information

Authors and Affiliations

  1. Department of Pharmaceutics, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh, 11451, Saudi Arabia

    Sayed H. Auda, Mahmoud El-Badry & Faiyaz Shakeel

  2. Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Al-Azhar University, Assiut, Egypt

    Sayed H. Auda

  3. Department of Pharmaceutics, Faculty of Pharmacy, Assiut University, 71526, Assiut, Egypt

    Dina Fathalla, Gihan Fetih & Mahmoud El-Badry

Authors
  1. Sayed H. Auda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dina Fathalla
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gihan Fetih
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mahmoud El-Badry
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Faiyaz Shakeel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Faiyaz Shakeel.

Ethics declarations

Conflict of interest

The authors report no conflicts of interest in this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Auda, S.H., Fathalla, D., Fetih, G. et al. Niosomes as transdermal drug delivery system for celecoxib: in vitro and in vivo studies. Polym. Bull. 73, 1229–1245 (2016). https://doi.org/10.1007/s00289-015-1544-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00289-015-1544-8

Keywords

Search

Navigation